Novartis To Appeal FDA’s Summary Judgment Award In Generic Drug Approval Case
WASHINGTON, D.C. — Novartis Pharmaceuticals Corp. filed notice that it intends to appeal a decision by a District of Columbia district court judge to deny its motion for summary judgment and...To view the full article, register now.
Already a subscriber? Click here to view full article